Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Chromothripsis as an on-target consequence of CRISPR–Cas9 genome editing
by
Weiss, Mitchell J.
, Pellman, David
, Yao, Yu
, Zhang, Cheng-Zhong
, Papathanasiou, Stamatis
, Blaine, Logan J.
, Sun, Lili
, Leibowitz, Mitchell L.
, Doerfler, Phillip A.
in
14/19
/ 14/63
/ 45/23
/ 631/1647/1513
/ 631/208
/ 631/208/212
/ 631/208/514
/ 631/80
/ Abnormalities
/ Agriculture
/ Anemia, Sickle Cell - genetics
/ Animal Genetics and Genomics
/ Antigens, CD34 - metabolism
/ Biomedical and Life Sciences
/ Biomedicine
/ Blood diseases
/ Cancer
/ Cancer Research
/ Cell cycle
/ Cell Division
/ Chromosome rearrangements
/ Chromosomes
/ Chromosomes, Human - genetics
/ Chromothripsis
/ Congenital diseases
/ CRISPR
/ CRISPR-Associated Protein 9 - metabolism
/ CRISPR-Cas Systems - genetics
/ Deoxyribonucleic acid
/ DNA
/ DNA Cleavage
/ DNA damage
/ Editing
/ Gene Editing
/ Gene Function
/ Gene sequencing
/ Genes
/ Genome editing
/ Genome, Human
/ Genomes
/ Human chromosome abnormalities
/ Human Genetics
/ Humans
/ Micronuclei
/ Micronucleus, Germline - genetics
/ Risk factors
/ Sickle cell disease
/ Tumor Suppressor Protein p53 - metabolism
/ Whole genome sequencing
2021
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Chromothripsis as an on-target consequence of CRISPR–Cas9 genome editing
by
Weiss, Mitchell J.
, Pellman, David
, Yao, Yu
, Zhang, Cheng-Zhong
, Papathanasiou, Stamatis
, Blaine, Logan J.
, Sun, Lili
, Leibowitz, Mitchell L.
, Doerfler, Phillip A.
in
14/19
/ 14/63
/ 45/23
/ 631/1647/1513
/ 631/208
/ 631/208/212
/ 631/208/514
/ 631/80
/ Abnormalities
/ Agriculture
/ Anemia, Sickle Cell - genetics
/ Animal Genetics and Genomics
/ Antigens, CD34 - metabolism
/ Biomedical and Life Sciences
/ Biomedicine
/ Blood diseases
/ Cancer
/ Cancer Research
/ Cell cycle
/ Cell Division
/ Chromosome rearrangements
/ Chromosomes
/ Chromosomes, Human - genetics
/ Chromothripsis
/ Congenital diseases
/ CRISPR
/ CRISPR-Associated Protein 9 - metabolism
/ CRISPR-Cas Systems - genetics
/ Deoxyribonucleic acid
/ DNA
/ DNA Cleavage
/ DNA damage
/ Editing
/ Gene Editing
/ Gene Function
/ Gene sequencing
/ Genes
/ Genome editing
/ Genome, Human
/ Genomes
/ Human chromosome abnormalities
/ Human Genetics
/ Humans
/ Micronuclei
/ Micronucleus, Germline - genetics
/ Risk factors
/ Sickle cell disease
/ Tumor Suppressor Protein p53 - metabolism
/ Whole genome sequencing
2021
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Chromothripsis as an on-target consequence of CRISPR–Cas9 genome editing
by
Weiss, Mitchell J.
, Pellman, David
, Yao, Yu
, Zhang, Cheng-Zhong
, Papathanasiou, Stamatis
, Blaine, Logan J.
, Sun, Lili
, Leibowitz, Mitchell L.
, Doerfler, Phillip A.
in
14/19
/ 14/63
/ 45/23
/ 631/1647/1513
/ 631/208
/ 631/208/212
/ 631/208/514
/ 631/80
/ Abnormalities
/ Agriculture
/ Anemia, Sickle Cell - genetics
/ Animal Genetics and Genomics
/ Antigens, CD34 - metabolism
/ Biomedical and Life Sciences
/ Biomedicine
/ Blood diseases
/ Cancer
/ Cancer Research
/ Cell cycle
/ Cell Division
/ Chromosome rearrangements
/ Chromosomes
/ Chromosomes, Human - genetics
/ Chromothripsis
/ Congenital diseases
/ CRISPR
/ CRISPR-Associated Protein 9 - metabolism
/ CRISPR-Cas Systems - genetics
/ Deoxyribonucleic acid
/ DNA
/ DNA Cleavage
/ DNA damage
/ Editing
/ Gene Editing
/ Gene Function
/ Gene sequencing
/ Genes
/ Genome editing
/ Genome, Human
/ Genomes
/ Human chromosome abnormalities
/ Human Genetics
/ Humans
/ Micronuclei
/ Micronucleus, Germline - genetics
/ Risk factors
/ Sickle cell disease
/ Tumor Suppressor Protein p53 - metabolism
/ Whole genome sequencing
2021
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Chromothripsis as an on-target consequence of CRISPR–Cas9 genome editing
Journal Article
Chromothripsis as an on-target consequence of CRISPR–Cas9 genome editing
2021
Request Book From Autostore
and Choose the Collection Method
Overview
Genome editing has therapeutic potential for treating genetic diseases and cancer. However, the currently most practicable approaches rely on the generation of DNA double-strand breaks (DSBs), which can give rise to a poorly characterized spectrum of chromosome structural abnormalities. Here, using model cells and single-cell whole-genome sequencing, as well as by editing at a clinically relevant locus in clinically relevant cells, we show that CRISPR–Cas9 editing generates structural defects of the nucleus, micronuclei and chromosome bridges, which initiate a mutational process called chromothripsis. Chromothripsis is extensive chromosome rearrangement restricted to one or a few chromosomes that can cause human congenital disease and cancer. These results demonstrate that chromothripsis is a previously unappreciated on-target consequence of CRISPR–Cas9-generated DSBs. As genome editing is implemented in the clinic, the potential for extensive chromosomal rearrangements should be considered and monitored.
Chromothripsis, a chromosomal shattering event, can be elicited by micronuclei and chromosome bridges formed by CRISPR–Cas9-generated double-stranded breaks. Extensive chromosomal rearrangements may thus be an on-target effect of genome editing.
Publisher
Nature Publishing Group US,Nature Publishing Group
Subject
/ 14/63
/ 45/23
/ 631/208
/ 631/80
/ Anemia, Sickle Cell - genetics
/ Animal Genetics and Genomics
/ Biomedical and Life Sciences
/ Cancer
/ Chromosomes, Human - genetics
/ CRISPR
/ CRISPR-Associated Protein 9 - metabolism
/ CRISPR-Cas Systems - genetics
/ DNA
/ Editing
/ Genes
/ Genomes
/ Human chromosome abnormalities
/ Humans
/ Micronucleus, Germline - genetics
This website uses cookies to ensure you get the best experience on our website.